Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| NUVL | Flynn James E | Director | 07/15/2026 | Abgabe | 124.00 | 3,444 | 427,056 | Form 4 |
| NUVL | Flynn James E | Director | 07/15/2026 | U | 124.00 | 5,146 | 638,104 | Form 4 |
| NUVL | Flynn James E | Director | 07/15/2026 | Abgabe | 124.00 | 650,000 | 80,600,000 | Form 4 |
| NUVL | Flynn James E | Director | 07/15/2026 | Abgabe | 124.00 | 8,299,225 | 1,029,103,900 | Form 4 |
| NUVL | Meyers Michael L. | Director | 07/15/2026 | Abgabe | — | 3,444 | — | Form 4 |
| NUVL | Meyers Michael L. | Director | 07/15/2026 | U | 124.00 | 5,146 | 638,104 | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 07/15/2026 | Abgabe | — | 14,350 | — | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 07/15/2026 | Zuteilung | — | 14,350 | — | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 07/15/2026 | Abgabe | — | 41,100 | — | Form 4 |
| NUVL | Balcom Alexandra | Chief Financial Officer | 07/15/2026 | U | 124.00 | 44,433 | 5,509,692 | Form 4 |
| NUVL | Srivastava Sapna | Director | 07/15/2026 | Abgabe | — | 3,444 | — | Form 4 |
| NUVL | Srivastava Sapna | Director | 07/15/2026 | U | 124.00 | 5,146 | 638,104 | Form 4 |
| NUVL | Oliger Christy J. | Director | 07/15/2026 | Abgabe | — | 6,091 | — | Form 4 |
| NUVL | Oliger Christy J. | Director | 07/15/2026 | U | 124.00 | 1,324 | 164,176 | Form 4 |
| NUVL | Squarer Ron | Director | 07/15/2026 | Abgabe | — | 6,281 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 07/15/2026 | Abgabe | — | 14,350 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 07/15/2026 | Zuteilung | — | 14,350 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 07/15/2026 | Abgabe | — | 41,100 | — | Form 4 |
| NUVL | Turner Christopher Durant | Chief Medical Officer | 07/15/2026 | U | 124.00 | 31,530 | 3,909,720 | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 07/15/2026 | Abgabe | — | 14,350 | — | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 07/15/2026 | Zuteilung | — | 14,350 | — | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 07/15/2026 | Abgabe | — | 41,100 | — | Form 4 |
| NUVL | Noci Darlene | Chief Development Officer | 07/15/2026 | U | 124.00 | 17,017 | 2,110,108 | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 07/15/2026 | Abgabe | — | 7,120 | — | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 07/15/2026 | Zuteilung | — | 7,120 | — | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 07/15/2026 | Abgabe | — | 29,433 | — | Form 4 |
| NUVL | Lane Benjamin | See Remarks | 07/15/2026 | U | 124.00 | 21,092 | 2,615,408 | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 07/15/2026 | Abgabe | — | 14,350 | — | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 07/15/2026 | Zuteilung | — | 14,350 | — | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 07/15/2026 | Abgabe | — | 41,100 | — | Form 4 |
| NUVL | Pelish Henry E. | Chief Scientific Officer | 07/15/2026 | U | 124.00 | 22,393 | 2,776,732 | Form 4 |
| NUVL | Porter James Richard | President and CEO | 07/15/2026 | Abgabe | — | 40,025 | — | Form 4 |
| NUVL | Porter James Richard | President and CEO | 07/15/2026 | Zuteilung | — | 40,025 | — | Form 4 |
| NUVL | Porter James Richard | President and CEO | 07/15/2026 | Abgabe | — | 121,350 | — | Form 4 |
| NUVL | Porter James Richard | President and CEO | 07/15/2026 | U | 124.00 | 203,529 | 25,237,596 | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 07/15/2026 | Abgabe | — | 14,350 | — | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 07/15/2026 | Zuteilung | — | 14,350 | — | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 07/15/2026 | Abgabe | — | 41,100 | — | Form 4 |
| NUVL | Miller Deborah Ann | Chief Legal Officer | 07/15/2026 | U | 124.00 | 18,534 | 2,298,216 | Form 4 |
| NUVL | Protopapas Anna | Director | 07/15/2026 | Abgabe | — | 3,444 | — | Form 4 |
| NUVL | Protopapas Anna | Director | 07/15/2026 | U | 124.00 | 5,146 | 638,104 | Form 4 |
| NUVL | Bogle Grant C. | Director | 07/15/2026 | Abgabe | — | 5,577 | — | Form 4 |
| NUVL | Bogle Grant C. | Director | 07/15/2026 | U | 124.00 | 3,714 | 460,536 | Form 4 |
| NUVL | Wheeler Cameron | Director | 07/15/2026 | Abgabe | — | 3,444 | — | Form 4 |
| NUVL | Wheeler Cameron | Director | 07/15/2026 | U | 124.00 | 5,146 | 638,104 | Form 4 |
| NUVL | Porter James Richard | President and CEO | 07/06/2026 | Verkauf | 123.72 | 30,000 | 3,711,600 | Form 4 |
| NUVL | Porter James Richard | President and CEO | 07/06/2026 | Optionsausübung | 18.93 | 30,000 | 567,900 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).